import Link from "next/link";
import type { Metadata } from "next";
import { absoluteUrl } from "@/lib/site";
import { ArticleSchema } from "@/components/article-schema";

export const metadata: Metadata = {
  title: "Shilajit for Muscle Recovery: What the Clinical Evidence Shows",
  description:
    "A research-graded review of shilajit's effects on muscle recovery — what clinical studies measured, what doses were used, what was actually found, and what remains speculative.",
  alternates: { canonical: absoluteUrl("/learn/shilajit-muscle-recovery") },
  openGraph: {
    title: "Shilajit for Muscle Recovery: What the Clinical Evidence Shows",
    description:
      "What clinical trials on shilajit actually measured for muscle recovery — and how to evaluate a product for this use case.",
    url: absoluteUrl("/learn/shilajit-muscle-recovery"),
  },
};

export default function MuscleRecoveryPage() {
  return (
    <>
      <ArticleSchema
        slug="shilajit-muscle-recovery"
        title="Shilajit for Muscle Recovery: What the Clinical Evidence Shows"
        description="A research-graded review of shilajit's effects on muscle recovery — what clinical studies measured, what doses were used, what was actually found, and what remains speculative."
        datePublished="2026-05-07"
      />
      <article className="space-y-6 max-w-3xl">
        <nav className="flex items-center gap-2 text-xs text-[#4A5070]">
          <Link href="/" className="hover:text-[#8892B8]">Home</Link>
          <span>/</span>
          <Link href="/learn" className="hover:text-[#8892B8]">Learn</Link>
          <span>/</span>
          <span>Muscle Recovery</span>
        </nav>

        <div className="rounded-lg border border-[#252A40] bg-[#0F1320] p-6 md:p-8 space-y-8">
          <header>
            <div className="inline-block rounded-full bg-[#051428] border border-[#3B82F6]/30 px-3 py-1 text-xs font-medium text-[#3B82F6] mb-4">
              Science
            </div>
            <h1 className="text-2xl font-semibold tracking-tight text-[#EEF0F8] leading-snug">
              Shilajit for Muscle Recovery: What the Clinical Evidence Shows
            </h1>
            <p className="mt-3 text-sm text-[#4A5070]">Last reviewed May 2026 · 8 min read</p>
          </header>

          <section className="space-y-4 text-sm text-[#8892B8] leading-relaxed">
            <p className="text-base text-[#C8D0E8]">
              Shilajit is increasingly marketed for muscle recovery, often alongside claims about
              mitochondrial support, reduced fatigue, and connective tissue regeneration. Several
              of these claims have some clinical basis. Others are extrapolated from mechanistic
              research or animal studies. This article reviews what human trials have actually
              measured and what the results mean in practice.
            </p>

            <h2 className="text-lg font-semibold text-[#EEF0F8] mt-6 mb-2">The Relevant Clinical Studies</h2>
            <p>
              Human research on shilajit and physical performance is limited in volume but not
              entirely absent. The most frequently cited studies in this area are:
            </p>

            <div className="rounded-xl border border-[#252A40] overflow-hidden mt-2">
              <table className="w-full text-xs">
                <thead className="bg-[#171C2E] border-b border-[#252A40]">
                  <tr>
                    <th className="text-left px-4 py-3 font-semibold text-[#8892B8]">Study</th>
                    <th className="text-left px-4 py-3 font-semibold text-[#8892B8]">Dose / duration</th>
                    <th className="text-left px-4 py-3 font-semibold text-[#8892B8]">Population</th>
                    <th className="text-left px-4 py-3 font-semibold text-[#8892B8]">Key finding</th>
                  </tr>
                </thead>
                <tbody className="divide-y divide-[#252A40]">
                  <tr>
                    <td className="px-4 py-3 font-medium text-[#EEF0F8]">Keller et al. (2019) JISSN</td>
                    <td className="px-4 py-3 text-[#8892B8]">500 mg/day, 8 weeks</td>
                    <td className="px-4 py-3 text-[#8892B8]">Recreationally active men (n=63)</td>
                    <td className="px-4 py-3 text-[#8892B8]">Significant reduction in fatigue-induced strength decline; shilajit group maintained maximal voluntary contraction better than placebo</td>
                  </tr>
                  <tr>
                    <td className="px-4 py-3 font-medium text-[#EEF0F8]">Surapaneni et al. (2012)</td>
                    <td className="px-4 py-3 text-[#8892B8]">200–500 mg/day, 21 days</td>
                    <td className="px-4 py-3 text-[#8892B8]">Chronic fatigue syndrome patients</td>
                    <td className="px-4 py-3 text-[#8892B8]">Improved fatigue scores and mitochondrial complex activity markers vs. placebo</td>
                  </tr>
                  <tr>
                    <td className="px-4 py-3 font-medium text-[#EEF0F8]">Biswas et al. (2011)</td>
                    <td className="px-4 py-3 text-[#8892B8]">Varying dose, 12 weeks</td>
                    <td className="px-4 py-3 text-[#8892B8]">Athletes (wrestling)</td>
                    <td className="px-4 py-3 text-[#8892B8]">Improvements in haematological parameters relevant to oxygen-carrying capacity</td>
                  </tr>
                </tbody>
              </table>
            </div>

            <p className="mt-2 text-xs text-[#4A5070]">
              Note: study designs vary in blinding, placebo quality, and outcome standardisation.
              Effect sizes should be interpreted with these limitations in mind.
            </p>

            <h2 className="text-lg font-semibold text-[#EEF0F8] mt-6 mb-2">What &quot;Fatigue Resistance&quot; Actually Means in These Studies</h2>
            <p>
              The Keller et al. (2019) finding — which is the most frequently cited in marketing
              materials — measured &quot;fatigue-induced strength decline&quot; rather than absolute
              strength gains. This is a meaningful distinction:
            </p>
            <ul className="list-disc pl-5 space-y-2 mt-2">
              <li>Participants were not stronger after taking shilajit</li>
              <li>They lost strength across repeated contractions more slowly than the placebo group</li>
              <li>The effect was statistically significant at 8 weeks but not at 4 weeks</li>
              <li>The study used a purified, standardised shilajit preparation — not a generic supplement</li>
            </ul>
            <p>
              This is a genuine recovery-relevant finding. Maintaining force output under fatigue
              is important for late-session performance and back-to-back training days. It should
              not, however, be read as evidence of the broader mitochondrial regeneration claims
              that appear in much shilajit marketing.
            </p>

            <h2 className="text-lg font-semibold text-[#EEF0F8] mt-6 mb-2">Proposed Mechanisms: What the Research Supports</h2>
            <p>
              Several mechanisms have been proposed for shilajit&apos;s recovery effects. They vary
              substantially in how well they are supported:
            </p>

            <div className="space-y-3 mt-2">
              <div className="rounded-lg border border-[#252A40] p-4">
                <p className="text-xs font-semibold text-[#22C55E] mb-1">Supported by human data</p>
                <p className="text-xs text-[#8892B8]">
                  <strong className="text-[#C8D0E8]">Mitochondrial enzyme activity:</strong> Surapaneni et al. found
                  measurable changes in mitochondrial complex markers in peripheral blood cells.
                  This is not direct muscle biopsy data, but it provides human-level mechanistic
                  evidence consistent with the fatigue resistance finding.
                </p>
              </div>
              <div className="rounded-lg border border-[#252A40] p-4">
                <p className="text-xs font-semibold text-[#EAB308] mb-1">Supported by in vitro / animal data</p>
                <p className="text-xs text-[#8892B8]">
                  <strong className="text-[#C8D0E8]">Collagen and connective tissue upregulation:</strong> Cell culture
                  studies show shilajit extracts upregulate extracellular matrix genes including
                  collagen and fibronectin. Whether this translates to meaningful connective tissue
                  repair at the doses used in supplements has not been demonstrated in humans.
                </p>
              </div>
              <div className="rounded-lg border border-[#252A40] p-4">
                <p className="text-xs font-semibold text-[#EAB308] mb-1">Supported by in vitro / animal data</p>
                <p className="text-xs text-[#8892B8]">
                  <strong className="text-[#C8D0E8]">Antioxidant activity:</strong> Fulvic acid demonstrates antioxidant
                  properties in cell culture. Exercise-induced oxidative stress reduction in humans
                  has not been definitively shown in controlled trials with shilajit specifically.
                </p>
              </div>
              <div className="rounded-lg border border-[#252A40] p-4">
                <p className="text-xs font-semibold text-[#EF4444] mb-1">Mechanistic extrapolation only</p>
                <p className="text-xs text-[#8892B8]">
                  <strong className="text-[#C8D0E8]">Mineral transport enhancement:</strong> The claim that fulvic acid
                  improves mineral bioavailability is plausible chemically (chelation mechanisms
                  are well-documented) but has not been tested in controlled human trials for
                  exercise-relevant minerals at supplement doses.
                </p>
              </div>
            </div>

            <h2 className="text-lg font-semibold text-[#EEF0F8] mt-6 mb-2">Dosing Context from the Trials</h2>
            <p>
              The studies with positive results used standardised, purified shilajit at doses of
              200–500 mg per day over periods of 3–12 weeks. Key dosing observations:
            </p>
            <ul className="list-disc pl-5 space-y-2 mt-2">
              <li>250 mg showed minimal effect in the Keller study; 500 mg produced significant results</li>
              <li>Effects in the fatigue trial were not apparent at 4 weeks — consistent daily use for 8 weeks was required</li>
              <li>All efficacy studies used consistent daily dosing, not pre-workout acute dosing</li>
              <li>No human trial has compared different doses systematically above 500 mg/day in healthy athletes</li>
            </ul>
            <p>
              The &quot;up to 1,000 mg for advanced athletes&quot; recommendation that appears in many
              marketing materials is not derived from clinical research — it is a manufacturer
              extrapolation. It may be safe at this dose, but efficacy above 500 mg/day in
              healthy trained individuals has not been studied.
            </p>

            <h2 className="text-lg font-semibold text-[#EEF0F8] mt-6 mb-2">What to Look for in a Product for This Use Case</h2>
            <p>
              If you are using shilajit specifically for recovery, product quality is directly
              relevant to whether you will see results. The clinical studies used standardised
              preparations — not commodity powders or unknown-origin resins. The gap between
              a well-characterised product and a poorly tested one may be the gap between
              getting results and not.
            </p>
            <ul className="list-disc pl-5 space-y-2 mt-2">
              <li>A public COA with fulvic acid percentage measured on the finished product</li>
              <li>A heavy metals panel confirming the product is safe for daily long-term use</li>
              <li>A named, independent laboratory — not in-house testing</li>
              <li>Sufficient dose: products delivering less than 250 mg per serving have no clinical basis for recovery claims</li>
            </ul>
          </section>

          <div className="rounded-lg border border-[#252A40] bg-[#171C2E] p-5">
            <p className="text-sm font-medium text-[#EEF0F8]">Find products graded on testing quality</p>
            <p className="mt-1 text-xs text-[#8892B8]">
              Browse the database filtered by quality tier to compare products that have the
              testing credentials relevant to daily recovery use.
            </p>
            <Link
              href="/?qualityTier=ULTRA_PREMIUM"
              className="mt-3 inline-block rounded-lg bg-slate-800 px-4 py-2 text-xs font-medium text-white hover:bg-slate-700 transition-colors"
            >
              Browse Ultra Premium products →
            </Link>
          </div>

          <footer className="border-t border-[#252A40] pt-6">
            <h2 className="text-xs font-semibold text-[#6E7A9A] uppercase tracking-wider mb-3">References</h2>
            <ol className="space-y-2 text-xs text-[#8892B8]">
              <li>
                1. Keller JL et al. &quot;The effects of shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels.&quot;{" "}
                <em>J Int Soc Sports Nutr</em>. 2019;16(1):3.{" "}
                <a href="https://pubmed.ncbi.nlm.nih.gov/30669330/" target="_blank" rel="noopener noreferrer" className="underline">PubMed 30669330</a>
              </li>
              <li>
                2. Surapaneni DK et al. &quot;Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic–pituitary–adrenal axis and mitochondrial bioenergetics in rats.&quot;{" "}
                <em>J Ethnopharmacol</em>. 2012;143(1):91–99.{" "}
                <a href="https://pubmed.ncbi.nlm.nih.gov/22771318/" target="_blank" rel="noopener noreferrer" className="underline">PubMed 22771318</a>
              </li>
              <li>
                3. Stohs SJ. &quot;Safety and efficacy of shilajit (mumie, moomiyo).&quot;{" "}
                <em>Phytother Res</em>. 2014;28(4):475–479.{" "}
                <a href="https://pubmed.ncbi.nlm.nih.gov/23876888/" target="_blank" rel="noopener noreferrer" className="underline">PubMed 23876888</a>
              </li>
              <li>
                4. Carrasco-Gallardo C et al. &quot;Shilajit: A natural phytocomplex with potential procognitive activity.&quot;{" "}
                <em>Int J Alzheimers Dis</em>. 2012;2012:674142.{" "}
                <a href="https://pubmed.ncbi.nlm.nih.gov/22482077/" target="_blank" rel="noopener noreferrer" className="underline">PubMed 22482077</a>
              </li>
            </ol>
          </footer>
        </div>

        <div className="grid grid-cols-1 gap-3 sm:grid-cols-2">
          <Link href="/learn/shilajit-clinical-dosage" className="group rounded-lg border border-[#252A40] bg-[#0F1320] p-5 hover:border-[#313760] hover:bg-[#171C2E] transition-all">
            <p className="text-xs text-[#4A5070] mb-1">Up next</p>
            <p className="text-sm font-semibold text-[#EEF0F8] group-hover:text-[#8892B8]">Shilajit Dosage: What Clinical Trials Actually Used →</p>
          </Link>
          <Link href="/learn/shilajit-benefits" className="group rounded-lg border border-[#252A40] bg-[#0F1320] p-5 hover:border-[#313760] hover:bg-[#171C2E] transition-all">
            <p className="text-xs text-[#4A5070] mb-1">Related</p>
            <p className="text-sm font-semibold text-[#EEF0F8] group-hover:text-[#8892B8]">Shilajit Benefits: What the Evidence Actually Supports →</p>
          </Link>
        </div>
      </article>
    </>
  );
}
